维普中文期刊产品整合服务
52篇 您的检索式:作者名="Lersch"
    题名 作者 年代 出处 被引量
1Capecitabine plus docetaxel evety 3 weeks in first-and second-line metastatic oesophageal cancer: final results of a phase Ⅱ trial 显示文摘Lorenzen S Duyster J Lersch C 2005Br J Cancer2005,92,12:1
2Acute Oxaliplatin-induced peripheral Nerve Hyperexcitability显示文摘Schmelz R Lersch C 2002clin oncol2002,20,16:1
3Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5 -FU -chemotherapy in advanced ade- nocarcinoma of the pancreas 显示文摘ZIMMERMANN FB JEREMIC B LERSCH C 2005Hepatogastroenterology2005,52,61:1
4Capecitabine plus docetaxel every 3 weeks in first-and second-line metastatic esophageal cancer:final results of a phase II trial显示文摘Lorenzen S Duyster J Lersch C 2005Br J Cancer2005,92,12:1
5Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer显示文摘Lersch C Schmelz R Eckel F 2002Clin Colorectal Cancer2002,2,1:1
6Capecitabine for treatment of advanced hepatocellular carcinoma显示文摘Von Delius S Lersch C Mayr M 0,,80:1
7Capecitabine plus doeetaxel every3weeks in first-and second-line metastatic oesophageal cancer:final results of a phase11trial显示文摘Lorenzen S Duyster J Lersch C 2007Br J Cancer2007,92,12:1
8Prevention of oxaliplatininduced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer显示文摘Lersch C Schmelz R Eckel F 2002Clin Colorectal Cancer2002,2,1:1
9Capecitabine for treatment of advanced hepatocellular carcinoma显示文摘von Delius S Lersch C Mayr M 2007Hepatogastroenterology2007,54,80:1
10Prophylaxis of port system -associated thromboses in advanced oncolo- gy patients using heparin flushing显示文摘Lersch C Kotowa W Fung S 2004Journal of Cancer Research and Clinical Oncology2004,130,4:1
11Capecitabine plus docetaxel every 3 weeks in first-and second-line metastatic oesophageal cancer:final results of a phase Ⅱ trial显示文摘LORENZEN S DUYSTER J LERSCH C 2005British Journal of Cancer2005,92,12:1
12Capecitabine plus docetaxel every 3weeks in first and second-line metastatic oesophageal cancer: final results of a phase Ⅱ trial显示文摘Lorenzen S Duyster J Lersch C 2005Br J Cancer2005,92,12:1
13Capecitabine plus doeetaxel every 3 weeks in first-and second-line metastatic oesophageal cancer:final results of a phase 11 trial显示文摘Lorenzen S Duyster J Lersch C 2007Br J Cancer2007,92,12:1
14Prevention of oxliplatin induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer显示文摘Lersch C Schmelz R Eckel F 2002Clin Colorectal Cancer2002,2,1:1
15Preoperative radiological characterization of hepatic angiomyolipoma using magnetic resonance imaging and contrast - enhanced uhrasonography: a case report 显示文摘Krebs S Esposito 1 Lersch C 2011J Med Case Reports2011,26,5:1
16Synthesis and structural characterization of a fluorinated α-diimine platinum(Ⅱ) complex显示文摘Martin Lersch Alexander Krivokapic Mats Tilset 2007Organometallics2007,26,:1
17Capecitabine for treatment of advanced hepatocellular carcinoma显示文摘von Delius S Lersch C Mayr M 2007Hepatogast~''oenterology2007,54,80:1
18Acute oxaliplatininduced peripheral-nerve hyperexcitability显示文摘Schmelz R Lersch C Grem JL 2002Clin Oncol2002,20,:1
19The most commonly asked questions about huntington's disease显示文摘Steven M Lersch MD Diana Rosas MD 2001Neuroligist2001,7,:1
20Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal can- cer: final results of a phase II trial显示文摘Lorenzen S Duyster J Lersch C 2005Br J Cancer2005,92,12:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费